Cancer is a growing public health problem; it is responsible annually for millions of deaths
worldwide. Fluoropyrimidines are highly effective and commonly prescribed anti-neoplastic …

Cardio-oncology is a discipline based on early screening, monitoring, and treating
chemotherapy-induced cardiotoxicity. There are many chemotherapeutics known for their …

Opinion statement Fluoropyrimidine (FP) is used to treat a wide range of cancers; however, it
is associated with drug-induced vascular toxicity, as well as angina pectoris and coronary …

The fluoropyrimidines, namely 5-fluorouracil (5-FU) and its oral prodrug, capecitabine, are
the third most commonly used chemotherapeutic agents for the treatment of solid tumors of …

Abstract Fluoropyrimidines—5-fluorouracil (5-FU) and capecitabine—have been implicated
as cardiotoxic chemotherapy agents. This rare, albeit potentially serious toxicity has been …

Fluoropyrimidines such as 5-fluorouracil (5-FU) form the foundation of a wide variety of
chemotherapy regimens. 5-FU is in fact the third most commonly used chemotherapeutic …

Abstract Background The fluoropyrimidines, 5‐fluorouracil (5‐FU) and capecitabine, are
commonly used chemotherapeutic agents that have been associated with coronary …

Advancements in cancer treatments have improved survival rates but have also led to
increased cardiotoxicities, which can cause adverse cardiovascular events or worsen pre …

Abstract Background Cardiotoxicity associated with 5-Fluorouracil (5FU) administration has
been infrequently reported in literature, albeit various series of acute coronary syndromes …

Abstract Fluoropyrimidines (5-fluorouracil and capecitabine) are antimetabolite drugs,
widely used for the treatment of a variety of cancers, both in adjuvant and in metastatic …